Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, et al.
American Heart Journal
|
August 25, 2015
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
Christopher M Kramer, Evan Appelbaum, Milind Y Desai, et al.
Journal of Medical Internet Research
|
November 10, 2023
Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study
Robert Avram, Julia Byrne, Derek So, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Journal of the American College of Cardiology
|
November 9, 2019
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Stefan Neubauer, Paul Kolm, Carolyn Y Ho, et al.
JAMA
|
August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L Pereira, Michael E Farkouh, Derek So, et al.
Blood Advances
|
October 29, 2024
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease
Mark C Walters, Mary Eapen, Yiwen Liu, et al.
Blood Advances
|
November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study
Andrew S Artz, Brent R Logan, Wael Saber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2024
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, et al.
American Heart Journal
|
August 25, 2015
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
Christopher M Kramer, Evan Appelbaum, Milind Y Desai, et al.
Journal of Medical Internet Research
|
November 10, 2023
Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study
Robert Avram, Julia Byrne, Derek So, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Journal of the American College of Cardiology
|
November 9, 2019
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Stefan Neubauer, Paul Kolm, Carolyn Y Ho, et al.
JAMA
|
August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L Pereira, Michael E Farkouh, Derek So, et al.
Blood Advances
|
October 29, 2024
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease
Mark C Walters, Mary Eapen, Yiwen Liu, et al.
Blood Advances
|
November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study
Andrew S Artz, Brent R Logan, Wael Saber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2024
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Page
of 6